Name
Antigens
Accession Number
DBCAT000035
Description

Substances that are recognized by the immune system and induce an immune reaction.

Drugs
DrugDrug Description
EnfuvirtideAn HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals.
AdecatumumabInvestigated for use/treatment in breast cancer and prostate cancer.
Keyhole limpet hemocyaninInvestigated for use/treatment in bladder cancer and solid tumors.
PRO-542Investigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections, HIV infection, and pediatric indications.
BambermycinsBambermycins are antibiotic complexes which are retrieved from the organism, Streptomyces bambergiensis. They are used as an additive in food ingested by chickens and swine. The bambermycin complex of antibiotics...
Tuberculin purified protein derivativeA purified protein used in the Mantoux test for Mycobacterium tuberculosis testing.
Meningococcal polysaccharide vaccine group AMeningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and...
p-PhenylenediamineNot Annotated
Hepatitis B Vaccine (Recombinant)A solution of Hepatitis B surface antigen used to immunize patients against Hepatitis B.
Axicabtagene ciloleucelA CAR T cell therapy for relapsed or refractory large B-cell lymphoma, diffuse large B-cell lymphoma, primary mediastinal large B-cell lymphoma, high grade B-cell lymphoma, and diffuse large B-cell lymphoma from follicular lymphoma.
O-(N-acetyl-alpha-D-galactosaminyl)-L-serineNot Available
Human blood group H type 1 trisaccharideNot Available
Eftilagimod alfaEftilagimod alfa is under investigation in clinical trial NCT02614833 (IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma).
Zinc glycinateGlycoprotein marker of gastrointestinal cancer.
Ceramide NPCeramide NP is a lipid molecule included in a group of lipid molecules called ceramides. Ceramides are major lipid components in the stratum corneum of the human skin. Ceramide 3...
Squaric acid dibutyl esterSquaric acid dibutyl ester is under investigation in clinical trial NCT01971385 (Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis).
Blatella germanicaAn extract from Blatella germanica used in allergy testing.
Rhizopus arrhizus var. arrhizusAn extract from Rhizopus arrhizus var. arrhizus used in allergy testing.
Ustilago nuda hordeiAn extract from Ustilago nuda hordei used in allergy testing.
Ditiocarb zincDitiocarb Zinc is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6...
EthylenediamineEthylenediamine is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years...
BromothalonilBromothalonil is approved for use within allergenic epicutaneous patch tests which are indicated for use as an aid in the diagnosis of allergic contact dermatitis (ACD) in persons 6 years...
Disperse Blue 106Disperse Blue 106 is used in allergenic testing.
Dermatophagoides farinaeAn extract from Dermatophagoides farinae used in allergy testing.
Dermatophagoides pteronyssinusAn extract from Dermatophagoides pteronyssinus used in allergy testing.
Iodopropynyl butylcarbamateNot Annotated
BevifimodBevifimod is under investigation in clinical trial NCT01749787 (Safety Study of PRTX-100 With Methotrexate or Leflunomide to Treat Active Rheumatoid Arthritis).
EritoranInvestigated for use/treatment in sepsis and septicemia.
TifuvirtideInvestigated for use/treatment in acquired immune deficiency syndrome (AIDS) and aids-related infections and HIV infection.
GI-5005Investigated for use/treatment in hepatitis (viral, C).
Nelipepimut-SInvestigated for use/treatment in prostate cancer and breast cancer.
E5531Investigated for use/treatment in sepsis and septicemia.
Xanthan gumXanthan gum is a polysaccharide gum derived from* Xanthomonas campestris* by a pure-culture fermentation process and purified by recovery with isopropyl alcohol. The major constituents include D-glucose, D-mannose, and D-glucuronic...
DinitrochlorobenzeneDinitrochlorobenzene has been used in trials studying the treatment of HIV Infections.
Meningococcal polysaccharide vaccine group CMeningococcal group C polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup C. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and...
Melanoma antigen recognized by T-cells 1Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery).
Moderna COVID-19 VaccineAn mRNA vaccine for the prevention of COVID-19, the disease caused by the SARS-CoV-2 virus, in patients aged 18 years and older.
BNT162b1 SARS-CoV-2 VaccineBNT162b1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding...
Pfizer-BioNTech COVID-19 VaccineAn mRNA vaccine for the prevention of COVID-19, the disease caused by the SARS-CoV-2 virus.
Bizalimogene ralaplasmidBizalimogene ralaplasmid is under investigation in clinical trial NCT03499795 (VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 And/or HPV-18 Related Anal or Anal/peri-anal, High Grade...
PidacmeranPidacmeran is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
BNT-162A1BNT-162A1 is under investigation in clinical trial NCT04380701 (A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults).
EpiVacCoronaEpiVacCorona Vaccine, developed by the Vektor State Research Center of Virology and Biotechnology in Russia, is based on peptide-antigens that facilitate immunity to the SARS-CoV-2 virus . It is currently...
ReltecimodReltecimod is under investigation in clinical trial NCT02469857 (Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections).
Drugs & Drug Targets
DrugTargetType
EnfuvirtideEnvelope glycoproteintarget
EnfuvirtideCytochrome P450 2C19enzyme
EnfuvirtideCytochrome P450 2E1enzyme
Keyhole limpet hemocyaninInterleukin-2target
PRO-542Free fatty acid receptor 4target
Tuberculin purified protein derivativeToll-like receptor 2target
Axicabtagene ciloleucelB-lymphocyte antigen CD19target
Human blood group H type 1 trisaccharideHisto-blood group ABO system transferasetarget
EritoranToll-like receptor 4target
TifuvirtidePlasma serine protease inhibitortarget
Nelipepimut-SHLA class I histocompatibility antigen, A-2 alpha chaintarget
Nelipepimut-SHLA class I histocompatibility antigen, A-3 alpha chaintarget
E5531Toll-like receptor 4target
DinitrochlorobenzeneMethylated-DNA--protein-cysteine methyltransferasetarget
DinitrochlorobenzeneGlutathione S-transferase Ptarget